Novavax announces very successful bird flu vaccination results
WASHINGTON The Rockville, Md.-based biotech Novavax announced Tuesday that trials of its bird flu vaccine resulted in 94 percent of test subjects producing antibodies to the deadly H5N1 strain.
Unlike other flu vaccines, which are grown using viruses in eggs, the Novavax vaccine uses particles similar in structure to the virus but unable to replicate.
The H5N1 strain has been linked to 110 deaths since 2005. Many experts fear that the strain, spread through direct contact between people and birds, could mutate into an airborne strain and lead to a pandemic.
King’s $1.4 billion bid rejected by Alpharma
NEW YORK King Pharmaceuticals would gain access to a transdermal patch to treat pain if it acquired Alpharma.
So far, however, Alpharma isn’t interested in King’s $1.4 billion cash offer to acquire the company and its NSAID patch Flector and the Kadian extended-release morphine product, saying in a written statement that King’s three bids for the company since July have undervalued the company.
“We are willing to entertain a proposal from you that we believe more appropriately values the company,” Alpharma chief executive officer Dean Mitchell wrote in a letter to King chief executive officer Brian Markison. “To that end, we remain open to discussions with you at a price that we believe reflects the inherent value of Alpharma.”
LDL cholesterol levels linked to cancers in diabetics
NEW YORK LDL cholesterol has been linked to higher risk of cancer in patients with Type 2 diabetes, according to a study.
The study, conducted by researchers in Hong Kong, examined 6,107 patients with diabetes, none of whom took statins to lower cholesterol. It found that patients with LDL cholesterol levels less than 2.8 millimoles per liter of blood had higher risk of cancers in the digestive, reproductive, lymphatic and circulatory systems. Meanwhile, patients with levels greater than 3.8 millimoles had more risk of oral, bone, skin, breast and connective tissue cancers.
The researchers published their study in the Canadian Medical Association Journal.